Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140
Authors:
Open Access
- 19 August 2022
- journal article
- research article
- Published by Springer Nature in BMC Biology
- Vol. 20 (1) , 1-27
Abstract
Background: SP140 is a bromodomain-containing protein expressed predominantly in immune cells. Genetic polymorphisms and epigenetic modifications in the SP140 locus have been linked to Crohn’s disease (CD), suggesting a role in inflammation. Results: We report the development of the first small molecule SP140 inhibitor (GSK761) and utilize this to elucidate SP140 function in macrophages. We show that SP140 is highly expressed in CD mucosal macrophages and in in vitro-generated inflammatory macrophages. SP140 inhibition through GSK761 reduced monocyte-to-inflammatory macrophage differentiation and lipopolysaccharide (LPS)-induced inflammatory activation, while inducing the generation of CD206+ regulatory macrophages that were shown to associate with a therapeutic response to anti-TNF in CD patients. SP140 preferentially occupies transcriptional start sites in inflammatory macrophages, with enrichment at gene loci encoding pro-inflammatory cytokines/chemokines and inflammatory pathways. GSK761 specifically reduces SP140 chromatin binding and thereby expression of SP140-regulated genes. GSK761 inhibits the expression of cytokines, including TNF, by CD14+ macrophages isolated from CD intestinal mucosa. Conclusions: This study identifies SP140 as a druggable epigenetic therapeutic target for CD.Keywords
All Related Versions
Funding Information
- H2020 European Research Council (ITN-2014-EID-641665, ITN-2014-EID-641665)
- Ministerie van Buitenlandse Zaken (TKI-LSH T2017)
This publication has 74 references indexed in Scilit:
- Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteinsJournal of Neurodevelopmental Disorders, 2013
- Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genesGut, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Targeting MYC dependence in cancer by inhibiting BET bromodomainsProceedings of the National Academy of Sciences, 2011
- Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent MannerGastroenterology, 2011
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociNature Genetics, 2010
- Defect in CEACAM family member expression in Crohnʼs disease IECs is regulated by the transcription factor SOX9Inflammatory Bowel Diseases, 2009
- Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1Journal of Virology, 2002
- Identification and Characterization of a Leukocyte-specific Component of the Nuclear BodyJournal of Biological Chemistry, 1996